American Financial Statements From 2010 to 2026

AONC Stock   11.50  0.00  0.00%   
American Oncology's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing American Oncology's valuation are provided below:
Gross Profit
120.5 M
Profit Margin
(0)
Market Capitalization
336.4 M
Enterprise Value Revenue
0.2706
Revenue
1.8 B
We have found one hundred twenty available fundamental signals for American Oncology Network, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of American Oncology's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road.

American Oncology Total Revenue

1.29 Billion

Check American Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among American Oncology's main balance sheet or income statement drivers, such as Net Income Applicable To Common Shares of 2.1 M, Income Tax Expense of 2.7 M or Tax Provision of 3 M, as well as many indicators such as Price To Sales Ratio of 0.0431, Dividend Yield of 0.0 or PTB Ratio of 4.04. American financial statements analysis is a perfect complement when working with American Oncology Valuation or Volatility modules.
  
Build AI portfolio with American Stock
Check out the analysis of American Oncology Correlation against competitors.

American Oncology Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets312.3 M540.9 M133.7 M
Slightly volatile
Other Current Liabilities21.3 M38.1 M9.2 M
Slightly volatile
Total Current Liabilities142.2 M249.4 M61.1 M
Slightly volatile
Other Liabilities4.7 M4.7 M3.6 M
Slightly volatile
Net Tangible Assets65.4 M69.9 M60.4 M
Slightly volatile
Accounts Payable125 M196.3 M93.7 M
Slightly volatile
Cash75.9 M72.3 M17.3 M
Slightly volatile
Non Current Assets Total167.7 M159.7 M40.4 M
Slightly volatile
Non Currrent Assets Other32.5 M31 M6.7 M
Slightly volatile
Other Assets5.6 M6.5 M7.2 M
Slightly volatile
Cash And Short Term Investments44.2 M83.5 M19.3 M
Slightly volatile
Net Receivables166.5 M218.1 M124.7 M
Slightly volatile
Common Stock Shares Outstanding21.3 M12.1 M27.4 M
Slightly volatile
Liabilities And Stockholders Equity331.3 M540.9 M139.9 M
Slightly volatile
Inventory43.6 M69.8 M31.3 M
Slightly volatile
Total Liabilities209.6 M416.7 M92.9 M
Slightly volatile
Total Current Assets233.1 M381.2 M98.5 M
Slightly volatile
Common Stock3.4 K3.6 K21.8 M
Pretty Stable
Property Plant Equipment50.2 M87.1 M41.9 M
Slightly volatile
Short and Long Term Debt Total128.3 M169.5 M86.2 M
Slightly volatile
Property Plant And Equipment Net79.9 M113.3 M49.6 M
Slightly volatile
Long Term Debt85.7 M100.2 M70.5 M
Slightly volatile
Non Current Liabilities Total130 M167.3 M90.2 M
Slightly volatile
Property Plant And Equipment Gross102.6 M147.6 M64.7 M
Slightly volatile
Capital Stock37.8 M74.7 M38.2 M
Pretty Stable
Non Current Liabilities Other9.9 M11.9 M7.1 M
Slightly volatile
Net Working Capital113.7 M131.8 M96.3 M
Slightly volatile
Intangible Assets1.7 M2.8 M1.3 M
Slightly volatile
Short Term Debt12.6 M11 M17.7 M
Slightly volatile
Good Will6.6 M12.5 M2.6 M
Slightly volatile
Short and Long Term DebtM3.4 M3.7 M
Slightly volatile

American Oncology Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income3.9 M3.7 M746.9 K
Slightly volatile
Depreciation And Amortization13.8 M22.3 MM
Slightly volatile
Interest Expense4.3 M8.1 M2.5 M
Slightly volatile
Selling General Administrative97.3 M154 M66.7 M
Slightly volatile
Total Revenue1.3 BB965.7 M
Slightly volatile
Gross Profit96.8 M135.5 M78.4 M
Slightly volatile
Other Operating Expenses1.3 BB956.6 M
Slightly volatile
Cost Of Revenue1.2 B1.9 B887.2 M
Slightly volatile
Total Operating Expenses105.2 M155.6 M69.4 M
Slightly volatile
Reconciled Depreciation13.8 M22.3 MM
Slightly volatile

American Oncology Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation11.7 M22.3 M6.3 M
Slightly volatile
Capital Expenditures13.3 M24.1 M12.6 M
Slightly volatile
Total Cash From Financing Activities67.1 M37.5 M56.5 M
Pretty Stable
End Period Cash Flow36.2 M72.3 M20.1 M
Slightly volatile
Change To Liabilities17 M12.7 M16.6 M
Very volatile
Begin Period Cash Flow29.6 M32.8 M14 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.04310.04540.312
Slightly volatile
Days Sales Outstanding52.9545.2451.668
Slightly volatile
Book Value Per Share4.067.092.1482
Slightly volatile
Stock Based Compensation To Revenue0.00860.00820.002
Slightly volatile
Capex To Depreciation1.531.242.538
Slightly volatile
EV To Sales0.09560.10.3331
Slightly volatile
Inventory Turnover21.5724.3425.2697
Very volatile
Days Of Inventory On Hand14.9315.5214.4033
Pretty Stable
Payables Turnover7.648.659.2354
Slightly volatile
Sales General And Administrative To Revenue0.05960.06850.0652
Slightly volatile
Capex To Revenue0.01180.01370.0146
Slightly volatile
Cash Per Share2.624.771.3997
Slightly volatile
Days Payables Outstanding42.0643.6639.3832
Slightly volatile
Intangibles To Total Assets0.02690.02560.0083
Slightly volatile
Current Ratio1.221.381.1937
Slightly volatile
Tangible Book Value Per Share3.866.212.0132
Slightly volatile
Receivables Turnover6.168.357.0857
Slightly volatile
Capex Per Share1.441.370.6499
Slightly volatile
Revenue Per Share63.0611547.958
Slightly volatile
Interest Debt Per Share5.7810.133.0838
Slightly volatile
Debt To Assets0.260.280.2744
Slightly volatile
Graham Number1.361.30.5706
Slightly volatile
Operating Cycle67.8860.7666.0713
Slightly volatile
Days Of Payables Outstanding42.0643.6639.3832
Slightly volatile
Ebt Per Ebit0.721.260.9447
Very volatile
Quick Ratio1.051.121.1041
Slightly volatile
Cash Ratio0.420.330.7463
Slightly volatile
Cash Conversion Cycle25.8317.1126.6893
Slightly volatile
Days Of Inventory Outstanding14.9315.5214.4033
Pretty Stable
Days Of Sales Outstanding52.9545.2451.668
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio4.954.721.6091
Slightly volatile
Fixed Asset Turnover21.2320.5425.7036
Slightly volatile
Debt Ratio0.260.280.2744
Slightly volatile
Price Sales Ratio0.04310.04540.312
Slightly volatile
Asset Turnover4.094.39.6 K
Slightly volatile
Gross Profit Margin0.08550.0770.0861
Slightly volatile

American Fundamental Market Drivers

About American Oncology Financial Statements

American Oncology stakeholders use historical fundamental indicators, such as American Oncology's revenue or net income, to determine how well the company is positioned to perform in the future. Although American Oncology investors may analyze each financial statement separately, they are all interrelated. For example, changes in American Oncology's assets and liabilities are reflected in the revenues and expenses on American Oncology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in American Oncology Network. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total RevenueB1.3 B
Cost Of Revenue1.9 B1.2 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.07  0.06 
Capex To Revenue 0.01  0.01 
Revenue Per Share 115.44  63.06 
Ebit Per Revenue(0.01)(0.01)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether American Oncology Network offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of American Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of American Oncology Network Stock. Outlined below are crucial reports that will aid in making a well-informed decision on American Oncology Network Stock:
Check out the analysis of American Oncology Correlation against competitors.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Will Health Care Providers & Services sector continue expanding? Could American diversify its offerings? Factors like these will boost the valuation of American Oncology. If investors know American will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every American Oncology data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.89)
Revenue Per Share
128.267
Quarterly Revenue Growth
0.514
Return On Assets
(0.02)
Return On Equity
(0.30)
Understanding American Oncology Network requires distinguishing between market price and book value, where the latter reflects American's accounting equity. The concept of intrinsic value - what American Oncology's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push American Oncology's price substantially above or below its fundamental value.
Understanding that American Oncology's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether American Oncology represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, American Oncology's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.